Chicken Flu Research Today is a free monthly online journal that collates and summarizes the latest research about Chicken Flu, including details on avian influenza, pandemic, symptoms, vaccines.

Volume 6 (2009), Issue 4 (April)

1. Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations.
   J Am Chem Soc, 131(13): 4702-9. [Abstract] [Full-text]
2. Universal detection and identification of avian influenza virus by use of resequencing microarrays.
   J Clin Microbiol, 47(4): 988-93. [Abstract] [Full-text]
3. Expression of mouse beta-defensin-3 in MDCK cells and its anti-influenza-virus activity.
   Arch Virol, 154(4): 639-47. [Abstract] [Full-text]
4. A comparison of the pathogenicity of avian and swine H5N1 influenza viruses in Indonesia.
   Arch Virol, 154(4): 677-81. [Abstract] [Full-text]
5. Analysis of N-glycans in embryonated chicken egg chorioallantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses.
   Glycoconj J, 26(4): 433-43. [Abstract] [Full-text]
6. Spatio-temporal epidemiology of highly pathogenic avian influenza outbreaks in the two deltas of Vietnam during 2003-2007.
   Prev Vet Med, 89(1): 16-24. [Abstract] [Full-text]
7. HA-Pseudotyped Retroviral Vectors for Influenza Antagonist Screening.
   J Biomol Screen, 14(3): 294-302. [Abstract] [Full-text]
8. Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and directed to clade 1 strains.
   Clin Vaccine Immunol, 16(4): 437-43. [Abstract] [Full-text]
9. Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.
   Clin Vaccine Immunol, 16(4): 558-66. [Abstract] [Full-text]
10. Using plant cells as influenza vaccine substrates.
    Expert Rev Vaccines, 8(4): 493-8. [Abstract] [Full-text]
11. Emulsion-based adjuvants for influenza vaccines.
    Expert Rev Vaccines, 8(4): 483-92. [Abstract] [Full-text]
12. Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.
    Expert Rev Vaccines, 8(4): 469-81. [Abstract] [Full-text]
13. Progress with human H5N1 vaccines: a perspective from industry.
    Expert Rev Vaccines, 8(4): 391-400. [Abstract] [Full-text]
14. A universal epitope-based influenza vaccine and its efficacy against H5N1.
    Vaccine, 27(15): 2099-107. [Abstract] [Full-text]
15. Distinct glycan topology for avian and human sialopentasaccharide receptor analogues upon binding different hemagglutinins: a molecular dynamics perspective.
    J Mol Biol, 387(2): 465-91. [Abstract] [Full-text]
16. Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice.
    J Virol, 83(9): 4704-8. [Abstract] [Full-text]
17. Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus.
    J Virol, 83(9): 4624-30. [Abstract] [Full-text]
18. Antibody recognition of a highly conserved influenza virus epitope.
    Science, 324(5924): 246-51. [Abstract] [Full-text]
19. The role of environmental transmission in recurrent avian influenza epidemics.
    PLoS Comput Biol, 5(4): e1000346. [Abstract] [Full-text]
20. Use of water-based foam to depopulate ducks and other species.
    Poult Sci, 88(5): 904-10. [Abstract] [Full-text]
21. Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea.
    J Virol, 83(9): 4205-15. [Abstract] [Full-text]
22. Systemic infection of avian influenza A virus H5N1 subtype in humans.
    Hum Pathol, 40(5): 735-9. [Abstract] [Full-text]
23. Identification of amino acid substitutions in mutated peptides of nucleoprotein from avian influenza virus.
    Talanta, 78(4): 1492-6. [Abstract] [Full-text]
24. Differential regulation of antiviral and proinflammatory cytokines and suppression of Fas-mediated apoptosis by NS1 of H9N2 avian influenza virus in chicken macrophages.
    J Gen Virol, 90: 1109-18. [Abstract] [Full-text]
25. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site.
    Nature, 458(7240): 909-13. [Abstract] [Full-text]
26. Evolution analysis of the matrix (M) protein genes of 17 H9N2 chicken influenza viruses isolated in northern China during 1998-2008.
    Virus Genes, 38(3): 398-403. [Abstract] [Full-text]
27. Codon volatility of hemagglutinin genes of H5N1 avian influenza viruses from different clades.
    Virus Genes, 38(3): 404-7. [Abstract] [Full-text]
28. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.
    Vaccine, 27(13): 1889-97. [Abstract] [Full-text]
29. Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken.
    Res Vet Sci, 86(3): 399-405. [Abstract] [Full-text]
30. Immune-related gene expression in response to H11N9 low pathogenic avian influenza virus infection in chicken and Pekin duck peripheral blood mononuclear cells.
    Mol Immunol, 46(8): 1744-9. [Abstract] [Full-text]
31. Avian influenza virus (H5N1); effects of physico-chemical factors on its survival.
    Virol J, 6: 38. [Abstract] [Full-text]
32. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.
    PLoS Med, 6(4): e1000049. [Abstract] [Full-text]
33. Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.
    J Virol, 83(10): 5192-203. [Abstract] [Full-text]
34. Are the Australian poultry industries vulnerable to large outbreaks of highly pathogenic avian influenza?
    Aust Vet J, 87(5): 165-74. [Abstract] [Full-text]
35. Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein.
    Biochem Biophys Res Commun, 382(4): 691-6. [Abstract] [Full-text]
36. Emerging and re-emerging viruses in Malaysia, 1997-2007.
    Int J Infect Dis, 13(3): 307-18. [Abstract] [Full-text]
37. Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam.
    Virology, 387(2): 250-6. [Abstract] [Full-text]
38. The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza.
    Virology, 387(2): 473-81. [Abstract] [Full-text]
39. The essential toxin: the changing perception of selenium in environmental sciences.
    Sci Total Environ, 407(12): 3620-33. [Abstract] [Full-text]
40. Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections.
    PLoS ONE, 4(4): e5336. [Abstract] [Full-text]

© 2004-2012 Chicken Flu Research Today. All Rights Reserved.